Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen

被引：12
|
作者：
Liew, Elena [1 ]
Atenafu, Eshetu G. [2 ]
Schimmer, Aaron D. [1 ]
Yee, Karen W. L. [1 ]
Schuh, Andre C. [1 ]
Minden, Mark D. [1 ]
Gupta, Vikas [1 ]
Brandwein, Joseph M. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 12期
关键词：
Leukemia; Lymphoblastic; Acute; Chemotherapy; Allogeneic stem cell transplantation; MINIMAL RESIDUAL DISEASE; STANDARD-RISK; THERAPY; MRD; AGE;
D O I：
10.1016/j.leukres.2012.08.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We analyzed the outcome of 46 patients with acute lymphoblastic leukemia (ALL) who relapsed following treatment with a pediatric-based protocol; 34 received intensive re-induction chemotherapy, with a CR2 rate of 62%, median overall survival (OS) 7.8 months, median relapse-free survival 5.2 months and one year OS 19%. Allogeneic HSCT was performed in 8 patients in CR2/3, with a median OS 2.2 months. OS was superior in patients who relapsed after completion of chemotherapy, compared to those relapsing on treatment. The outcome of adult ALL relapsing after treatment was therefore poor, and novel salvage strategies are needed to improve outcomes. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码：1517 / 1520
页数：4
相关论文
共 50 条
  • [21] Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen
    Reed, Daniel R.
    Wooster, Margaux
    Isom, Scott
    Ellis, Leslie R.
    Howard, Dianna S.
    Manuel, Megan
    Dralle, Sarah
    Lyerly, Susan
    Bhave, Rupali
    Powell, Bayard L.
    Pardee, Timothy S.
    ANNALS OF HEMATOLOGY, 2023, 102 (04) : 897 - 906
  • [22] The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia
    Benjamin, Jonathan E.
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 142 - 156
  • [23] Treatment of Pediatric Acute Lymphoblastic Leukemia
    Cooper, Stacy L.
    Brown, Patrick A.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2015, 62 (01) : 61 - +
  • [24] Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
    van der Ham, Cedric G.
    Suurenbroek, Lianne C.
    Kleisman, Michelle M.
    Antic, Zeljko
    Lelieveld, Stefan H.
    Yeong, Marley
    Westera, Liset
    Sonneveld, Edwin
    Hoogerbrugge, Peter M.
    van der Velden, Vincent H. J.
    van Leeuwen, Frank N.
    Kuiper, Roland P.
    LEUKEMIA, 2024, 38 (11) : 2366 - 2375
  • [25] New targeted therapies for relapsed pediatric acute lymphoblastic leukemia
    Pierro, Joanna
    Hogan, Laura E.
    Bhatla, Teena
    Carroll, William L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (08) : 725 - 736
  • [26] Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen
    Brandwein, Joseph M.
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Yee, Karen W. L.
    Schimmer, Aaron D.
    Gupta, Vikas
    Minden, Mark D.
    LEUKEMIA RESEARCH, 2014, 38 (05) : 532 - 536
  • [27] Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
    Hayashi, Hiroshi
    Makimoto, Atsushi
    Yuza, Yuki
    CANCERS, 2024, 16 (04)
  • [28] Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    von Stackelberg, Arend
    Locatelli, Franco
    Zugmaier, Gerhard
    Handgretinger, Rupert
    Trippett, Tanya M.
    Rizzari, Carmelo
    Bader, Peter
    O'Brien, Maureen M.
    Brethon, Benoit
    Bhojwani, Deepa
    Schlegel, Paul Gerhardt
    Borkhardt, Arndt
    Rheingold, Susan R.
    Cooper, Todd Michael
    Zwaan, Christian M.
    Barnette, Phillip
    Messina, Chiara
    Michel, Gerard
    DuBois, Steven G.
    Hu, Kuolung
    Zhu, Min
    Whitlock, James A.
    Gore, Lia
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4381 - +
  • [29] The pros and cons of probiotic use in pediatric oncology patients following treatment for acute lymphoblastic leukemia
    Simiakova, Miroslava
    Bielik, Viktor
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [30] Real-World Outcomes and Age-Related Analysis of Adult Acute Lymphoblastic Leukemia (ALL) Patients Treated With a Pediatric-Inspired Regimen
    Perusini, Maria Agustina
    Wei, Jonathan
    Vikas, Gupta
    Schuh, Andre
    Yee, Karen
    Maze, Dawn
    Bankar, Aniket
    Davidson, Marta
    Richard-Carpentier, Guillaume
    Chan, Steven
    Schimmer, Aaron
    Minden, Mark
    Sibai, Hassan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S278 - S279
12345